3 ms·
The DSM isn't about understanding how the brain works, it's about correlating sets of symptoms to treatments. If your issues are characterized by this broad set
by brooke2k 1y ago
The DSM isn't about understanding how the brain works, it's about correlating sets of symptoms to treatments. If your issues are characterized by this broad set of symptoms, then likely you'll benefit from these sorts of treatments, and etc. We don't have a good understanding of how the brain works, but we're pretty confident that people with schizophrenia often benefit from antipsychotic medications.
- hx8 1y agoIn some ways the financial conflicts of interest make sense, because the people that best understand a set of symptoms probably also are the ones in the best position to create new treatments. Being undisclosed makes it feel way more scummy than it might actually be.
- p_ing 1y agoThat should be true across medicine. A biotech is best suited to invent new medications for existing diseases consulting with or acquiring in-house talent that knows the disease inside and out. Experts generally benefit from their expertise. Nothing new, shouldn't be controversial.
- michaelt 1y agoThe thing is, society doesn't have to worry that the guy selling crutches is going to reinvent the definition of a broken leg to increase crutch sales.
- hx8 1y agoWe should worry about the guy selling crutches. He could be lobbying against safety standards that would decrease the number of broken legs. We should assume he's acting in his own best interest, and carefully consider if his actions align with our collective best interest. Disclosure is critical.